M&As this week: Yifan Pharmaceutical, BioClinica

10th November 2017 (Last Updated November 10th, 2017 00:00)

Yifan Pharmaceutical plans to acquire Hong Kong-based pharmaceutical products distributor NovoTek Pharmaceuticals for CNY136m ($20.6m).

Yifan Pharmaceutical plans to acquire Hong Kong-based pharmaceutical products distributor NovoTek Pharmaceuticals for CNY136m ($20.6m).

The Chinese pharmaceutical company will complete the acquisition through its subsidiary Billion-Fan International Pharmaceutical.

BioClinica has acquired research image management company MDDX.

BioClinica is a US-based pharmaceutical company and subsidiary of Cinven.

The transaction allows BioClinica to combine its scientific and medical imaging with MDDX’s advanced image management cloud technology.